View reference

Morgan SG, Kozyrskyj A, Metge C, Roos NP. Pharmaceuticals: Therapeutic interchange and pricing policies. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Report] [Summary]

Related terms
Access to Pharmaceutical Care
Actual Acquisition Cost Policy
Anatomical Therapeutic Chemical (ATC) Drug Classification System
Angiotensin Converting Enzyme Inhibitors (ACEIs)
Angiotensin II Receptor Antagonists (A2RAs)
Beta-Blocker
Canadian Pharmacists Association
Defined Daily Dose (DDD)
Dispensing Fees
Drug Benefits Management
Drug Product
Drug Reimbursement Policies
Generic Drugs
Generic Substitution Policies
Ingredient Cost
Manitoba Drug Benefits and Interchangeability Formulary
Maximum Allowable Cost Policy
Medicare
Patent
Prescribed Days Supplied
Prescribing Protocols
Prescription Cost
Prescriptions
Prescriptions Dispensed
Private Cost-Total
Public Cost-Total
Reference Based Pricing Policies
Special Authority Policies
Step-Down Approach
Step-Up Approach
Therapeutic Interchange
Therapeutic Interchange Policy
Units Dispensed

Keywords
costs
Deliverables-Prescription Drugs
Manitoba Report
pharmaceutical data
prescription costs